Annual Trading Update

RNS Number : 2153F
Victrex PLC
07 October 2008
 




Tuesday 7 October 2008


Victrex plc


Annual Trading Update



The Company announces its trading update for the year ended 30 September 2008.


As expected, sales volume for the year grew by 5% to approximately 2,625 tonnes (2007: 2,508 tonnes).  Second half sales volume of around 1,331 tonnes was up 9% on last year's second half (1,222 tonnes) and 3up on this year's first half (1,294 tonnes).


  • United States full year sales volume of 847 tonnes was 7% up on the previous year (791 tonnes). Second half sales volume of 429 tonnes was up 3% from 418 tonnes in the first half.

  • At 1,302 tonnes, European sales volume was 5% up on the previous year (1,243 tonnes) with second half sales volume of 656 tonnes, up 2% on the first half of this year (646 tonnes).

  • Asia-Pacific sales volume of 476 tonnes for the year was in line with 2007 (474 tonnes). Second half sales volume was 246 tonnes, 7% up on the first half of 230 tonnes.

  • Invibio®our biomaterial business, generated revenue of approximately £25.0for the year, an increase of 30over last year (£19.3m). At £13.3m, second half revenue grew by 14% compared with the first half (£11.7m).


Overall, we expect profits for the year to be in line with market expectations.



The announcement of the Company's results for the year ended 30 September 2008 will be made on Tuesday, 16 December 2008.


-Ends-



For further information please contact:


Victrex plc

Michael PeacockFinance Director




01253 897700


Hogarth Partnership Limited

Nick Denton / Barnaby Fry



0207 357 9477



  

Victrex plc is an innovative world leader in high performance materials through the manufacture of VICTREX® PEEK polymer, a high performance, easy to process thermoplastic.


VICTREX PEEK has a unique combination of chemical, wear, electrical, hydrolysis and temperature resistance, as well as excellent dimensional, mechanical and chemical stability combined with inherent purity and low flammability.


End users specify VICTREX PEEK to reduce systems costs, improve part performance, exploit greater design freedom and create a differentiated application. VICTREX PEEK is used across a broad range of applications in diverse markets including transport, industrial, electronics and medical. Invibio®, Victrex's biomaterial business, provides specialised solutions for medical device manufacturers.


The Group's headquarters are in the UK where its manufacturing facilities are based. This is complemented by a global network of sales, distribution and technical centres that serve more than 30 countries worldwide.


This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTFKAKQOBDDQKK

Companies

Victrex plc (VCT)
UK 100

Latest directors dealings